On the upside
Air Transport Services Group (Nasdaq: ATSG) completed a leasing agreement with principal client DHL.
Merge Healthcare will acquire Etrials Worldwide (Nasdaq: ETWC) in a cash and stock deal valued at approximately $18.3 million.
UBS analyst Michael Morris upgraded CBS (NYSE: CBS).
Aeterna Zentaris (Nasdaq: AEZS) reported upbeat Phase II clinical trial results for its colon and kidney cancer treatment Perifosine.
On the downside
Regions Financial (Nasdaq: RF) canceled an appearance at the Sanford C. Bernstein & Co. Strategic Decisions Conference last Friday.
Synta Pharmaceuticals (Nasdaq: SNTA) said that its melanoma treatment elesclomol failed a late stage clinical trial.
In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and by 3 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks climbed 19 points to 521.
